Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway. [electronic resource]
Producer: 20180510Description: 959-966 p. digitalISSN:- 1791-2423
- Amino Acid Chloromethyl Ketones -- administration & dosage
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- genetics
- Caspase 3 -- drug effects
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Survival -- drug effects
- Colorectal Neoplasms -- drug therapy
- DNA Fragmentation -- drug effects
- Humans
- Imidazoles -- administration & dosage
- MAP Kinase Signaling System -- drug effects
- Neoplasm Invasiveness -- genetics
- Peptides, Cyclic -- administration & dosage
- Phosphorylation -- drug effects
- Poly(ADP-ribose) Polymerases -- genetics
- Proto-Oncogene Proteins -- genetics
- Pyridines -- administration & dosage
- Tumor Suppressor Protein p53 -- genetics
- X-Linked Inhibitor of Apoptosis Protein -- genetics
- p38 Mitogen-Activated Protein Kinases -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.